Clinical Trial Update: Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma [Phase 2]

View source ↗

Summary

This Phase 2 dose‑response study evaluated inhaled tacrolimus in adults with moderate persistent asthma; the trial is now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Asthma, Bronchial, Bronchial Asthma | Phase 2 | Status: COMPLETED